A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Parkinson's Disease
Interventions
DRUG

Ampyra first, then Placebo

10 mg po bid for 4 weeks followed by placebo 4 weeks.

DRUG

placebo first, then Ampyra

placebo

Trial Locations (1)

33136

University of Miami, Miami

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Acorda Therapeutics

INDUSTRY

lead

University of Miami

OTHER